Khiron Life Sciences Corp.
KHRNF · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $21,506 | $22,392 | $45,174 | $37,335 |
| - Cash | $1,938 | $5,818 | $5,127 | $8,923 |
| + Debt | $2,564 | $2,343 | $2,789 | $2,227 |
| Enterprise Value | $22,132 | $18,917 | $42,836 | $30,639 |
| Revenue | $3,385 | $4,473 | $4,643 | $3,636 |
| % Growth | -24.3% | -3.7% | 27.7% | – |
| Gross Profit | $1,653 | $2,353 | $1,495 | $1,170 |
| % Margin | 48.8% | 52.6% | 32.2% | 32.2% |
| EBITDA | -$2,887 | -$2,519 | -$4,609 | -$2,959 |
| % Margin | -85.3% | -56.3% | -99.3% | -81.4% |
| Net Income | -$3,576 | -$2,171 | -$5,412 | -$19,501 |
| % Margin | -105.6% | -48.5% | -116.6% | -536.3% |
| EPS Diluted | -0.017 | -0.012 | -0.03 | -0.11 |
| % Growth | -44% | 61.6% | 72.5% | – |
| Operating Cash Flow | -$5,043 | -$2,000 | -$2,803 | -$5,166 |
| Capital Expenditures | -$873 | -$465 | -$317 | -$1,130 |
| Free Cash Flow | -$5,916 | -$2,465 | -$3,120 | -$6,296 |